Tekcapital’s portfolio company MicroSalt is set to launch a new range of innovative low-sodium products designed to reduce the health issues associated with high salt intake.

High salt intake is thought to cause 100,000 deaths a year in the US alone and be a major factor in millions more cases of high blood pressure.

MicroSalt’s new products are set to compliment initiatives by governments in the fight against deaths caused by high salt, especially the FDA’s drive to help reduce sodium intake. The FDA has conducted comprehensive studies into the impact of sodium and found huge numbers of people consume too much sodium.

To help lower the intake of sound by Americans, MicroSalt® is launching its new table salt shakers that will be unveiled at Expo the East Food convention in Philadelphia with sales beginning 1st October.

MicroSalt will distribute the new products through UNFI, North America’s premier food wholesaler and will list on Amazon.

After launching in the US this year, focus will move to UK, Western Europe and Canada in 2023.

“We are proud to be able to bring such an essential product to consumers nationwide. Sodium is one of the leading contributors to hypertension and these shakers can help minimize the negative impact that excess sodium consumption has on human health,” says Rick Guiney, CEO of MicroSalt®.

Tekcapital shares jumped 6% in early trade on Friday.